Skip to main content
Clinical Trials/NCT04596956
NCT04596956
Not yet recruiting
Phase 4

A Multicenter Randomized Controlled Trial on the Safety and Efficacy of Sodium Bicarbonate Ringer Injection in Elderly Patients Undergoing Abdominal Surgery

Chinese PLA General Hospital0 sites5,000 target enrollmentOctober 2020

Overview

Phase
Phase 4
Intervention
Lactated Ringer's solution
Conditions
Ringer Bicarbonate
Sponsor
Chinese PLA General Hospital
Enrollment
5000
Primary Endpoint
Complication rate (including death)
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

Objectives

  1. To observe whether sodium bicarbonate Ringer injections can reduce the incidence of postoperative complications in elderly patients undergoing abdominal surgery.
  2. To observe the effects of sodium bicarbonate Ringer injections on the internal environment, such as water, electrolytes, acid-base balance, and other physiological indexes, in the perioperative period of elderly patients undergoing abdominal surgery.

Research design:This study adopts a multicenter, prospective, randomized, controlled, pragmatic clinical trials (PCT) research design.

Sample size:5000 cases. Indication:The experimental group is the elderly patients undergoing abdominal surgery who were administered sodium bicarbonate Ringer injections intraoperatively; the control group is the elderly patients with abdominal surgery who were administered lactated Ringer's injections intraoperatively.

Observational index

Preoperative baseline data collection:

General patient information: basic information (age, height, and weight), preoperative diagnosis, past history, auxiliary examination results, etc.

Intraoperative data collection:

Perioperative vital signs information and arterial blood gas analysis results; The surgical method, operation time, and anaesthesia time; Intraoperative fluid management: The total amount of intraoperative fluids, blood transfusion volume, bleeding volume, urine volume, types and dosage of vasoactive drugs, diuretic dosage, sodium bicarbonate dosage.

Postoperative index:

Postoperative blood biochemical examination: liver function, renal function (urea nitrogen, creatinine), osmotic pressure, lactic acid, and blood sugar levels; Postoperative complications and treatment status Postoperative recovery: postoperative outcome, length of hospital stay, admission to ICU (duration of stay), postoperative eating time, out of bed activity time, gastrointestinal recovery time (exhaust), time for removal of various tubes (gastric tube, urinary tube, and drainage tube), etc.

The observation cut-off point is the patient's discharge. If the patient is still hospitalized 30 days after the operation, the observation will be terminated.

Research process

  1. Elderly abdominal surgery patients who meet the inclusion criteria will be enrolled and randomly divided into two groups according to the intraoperative application of extracellular fluid supplements. The experimental group is sodium bicarbonate Ringer injection group, and the control group is sodium lactate Ringer injection. Basic preoperative information of patients will be collected. The vital signs, fluid treatment, and surgical anaesthesia will be recorded during the operation, while the recovery and postoperative complications will be recorded during postoperative visits.
  2. The ability of sodium bicarbonate Ringer injections to reduce postoperative complications in elderly patients undergoing abdominal surgery will be observed.
  3. The effects of sodium bicarbonate Ringer injection on the internal environment, such as water, electrolytes, acid-base balance, and other physiological indexes in elderly patients undergoing abdominal surgery will be observed and compared.
  4. The safety and efficacy of sodium bicarbonate Ringer injection in elderly patients with abdominal diseases will be comprehensively assessed.
Registry
clinicaltrials.gov
Start Date
October 2020
End Date
December 2025
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Chinese PLA General Hospital
Responsible Party
Principal Investigator
Principal Investigator

Weidong Mi

Director of the Center for Anesthesia

Chinese PLA General Hospital

Eligibility Criteria

Inclusion Criteria

  • (1) Patients need to be over 65 years of age, while there is no restriction on gender.
  • (2) Patients are planned to undergo upper abdominal surgery under general anaesthesia, with an expected operation time of \>2 h, and the infusion volume is \>1000ml.
  • (3) The patient agrees to participate in the clinical research and signs the informed consent.

Exclusion Criteria

  • (1) Emergency surgery
  • (2) Hypermagnesemia (defined as serum Mg2+ \>1.25mmol/L)
  • (3) Patients who participated in other drug trials in the past 6 months
  • (4) Known allergic reactions to the test drug and/or its components
  • (5) Patients judged to lack the ability of providing informed consent
  • (6) Other situations considered unsuitable for enrollment by the researcher.

Arms & Interventions

Ringer lactate solution

Intervention: Lactated Ringer's solution

sodium bicarbonate Ringer injection

Intervention: sodium bicarbonate Ringer injection

Outcomes

Primary Outcomes

Complication rate (including death)

Time Frame: 30days

Complications include: bleeding, infection (incision infection, blood infection, urinary system infection), gastrointestinal complications (postoperative intestinal obstruction, anastomotic leakage), pulmonary complications (pulmonary infection, pulmonary embolism) ), cardiovascular complications (cardiac arrest, arrhythmia, heart failure, myocardial infarction), neurological complications (delirium, stroke), urinary system complications (renal insufficiency), etc. (refer to International Surgical Prognosis Study, ISOS ), and died during hospitalization.

Similar Trials